These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3469101)

  • 1. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
    Fowler PD; Dawes PT; John VA; Shotton PA
    Eur J Clin Pharmacol; 1986; 31(4):469-72. PubMed ID: 3469101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis.
    Fowler PD; Shadforth MF; Crook PR; John VA
    Eur J Clin Pharmacol; 1983; 25(3):389-94. PubMed ID: 6628528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of indomethacin and diclofenac on plasma and synovial prostaglandins in patients with rheumatoid arthritis].
    Szczepański L; Kowalewski J; Miturzyńska-Stryjecka H; Horubała-Bielak G
    Reumatologia; 1983; 21(2):149-56. PubMed ID: 6585872
    [No Abstract]   [Full Text] [Related]  

  • 5. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial fluid concentrations of diclofenac in patients with rheumatoid arthritis or osteoarthritis.
    Benson MD; Aldo-Benson M; Brandt KD
    Semin Arthritis Rheum; 1985 Nov; 15(2 Suppl 1):65-7. PubMed ID: 4081792
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
    Strusberg A; Montrull H; Meirovich CI
    Eur J Rheumatol Inflamm; 1983; 6(1):41-5. PubMed ID: 6574910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion.
    Gallacchi G; Marcolongo R
    Drugs Exp Clin Res; 1993; 19(3):95-7. PubMed ID: 8112204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effect of indoprofen in patients with rheumatoid arthritis.
    Caruso I; Moro E; Patrono C; Sacchetti G; Tamassia V; Tosolini GP
    Scand J Rheumatol; 1980; 9(2):123-6. PubMed ID: 7433927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis.
    McCrea JD; Telford AM; Kaye CM; Boyd MW
    Curr Med Res Opin; 1986; 10(2):73-81. PubMed ID: 3519094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of diclofenac following repeated topical applications of two diclofenac sodium formulations to minipigs.
    Wible JH; Barrett T; Devarakonda K; Giuliani M
    Biopharm Drug Dispos; 2014 Mar; 35(2):87-96. PubMed ID: 24122676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.
    Radermacher J; Jentsch D; Scholl MA; Lustinetz T; Frölich JC
    Br J Clin Pharmacol; 1991 May; 31(5):537-41. PubMed ID: 1888621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs.
    Bombardieri S; Cattani P; Ciabattoni G; Di Munno O; Pasero G; Patrono C; Pinca E; Pugliese F
    Br J Pharmacol; 1981 Aug; 73(4):893-901. PubMed ID: 6895043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
    Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
    Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro protein binding of diclofenac sodium in plasma and synovial fluid.
    Chan KK; Vyas KH; Brandt KD
    J Pharm Sci; 1987 Feb; 76(2):105-8. PubMed ID: 3572745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease.
    Crook PR; Willis JV; Kendall MJ; Jack DB; Fowler PD
    Eur J Clin Pharmacol; 1982; 21(4):331-4. PubMed ID: 7056279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin.
    Fowler PD; Dawes PT
    Eur J Clin Pharmacol; 1985; 27(6):689-91. PubMed ID: 3987775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases].
    Egg D; Günther R; Herold M; Kerschbaumer F
    Z Rheumatol; 1980; 39(5-6):170-5. PubMed ID: 7415586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.
    Bertin P; Lapicque F; Payan E; Rigaud M; Bailleul F; Jaeger S; Treves R; Netter P
    Eur J Clin Pharmacol; 1994; 46(1):3-7. PubMed ID: 8005184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.